The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism
Abstract
Background Because patients with rare familial homocystinuria who also carry factor V Leiden have an increased incidence of venous thromboembolism (VTE), we hypothesized an interrelation of moderate hyperhomocyst(e)inemia, factor V Leiden, and risk of VTE in the general population. Methods and Results In a large prospective cohort, we determined total homocysteine level and factor V Leiden mutation in baseline blood samples from 145 initially healthy men who subsequently developed VTE and among 646 men who remained free of vascular disease during a 10-year follow-up period. Hyperhomocyst(e)inemia was defined as a total homocysteine level above the 95th percentile (17.25 μmol/L). Compared with men with normal total homocysteine levels, those with hyperhomocyst(e)inemia had no increase in risk of any VTE but were at increased risk of idiopathic VTE (relative risk [RR]=3.4, P =.002). Compared with men without Leiden mutation, those with mutation were at increased risk of developing any VTE (RR=2.3, P =.005) as well as idiopathic VTE (RR=3.6, P =.0002). Compared with men with neither abnormality, those affected by both disorders had a 10-fold increase in risk of any VTE (RR=9.65, P =.009) and a 20-fold increase in risk of idiopathic VTE (RR=21.8, P =.0004). Conclusions Apparently healthy men with coexistent hyperhomocyst(e)inemia and Leiden mutation are at substantially increased risk of developing future VTEs, particularly those events considered idiopathic. In these data, the risk of VTE among doubly affected individuals was far greater than the sum of the individual risks associated with either abnormality alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuve, L. P., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-111 · Cited by 5,653
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341801 · Cited by 2,397
Self-citationFinal Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,264
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., & Graham, I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241701 · Cited by 2,161
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Self-citationA Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Self-citationKoster, T., Vandenbroucke, J., Rosendaal, F., de Ronde, H., Briët, E., & Bertina, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80081-9 · Cited by 1,239
Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis
Selhub, J., Jacques, P. F., Bostom, A. G., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O'Leary, D. H., Wolf, P. A., Schaefer, E. J., & Rosenberg, I. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320502 · Cited by 1,216
Self-citationResistance to Activated Protein C as a Basis for Venous Thrombosis
Svensson, P. J., & Dahlback, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402243300801 · Cited by 1,102
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
den Heijer, M., Koster, T., Blom, H. J., Bos, G. M. J., Briët, E., Reitsma, P. H., Vandenbroucke, J. P., & Rosendaal, F. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341203 · Cited by 1,044
Ridker, P. M., Hennekens, C. H., Lindpaintner, K., Stampfer, M. J., Eisenberg, P. R., & Miletich, J. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321403 · Cited by 1,035
Self-citationHeterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease
Boers, G. H. J., Smals, A. G. H., Trijbels, F. J. M., Fowler, B., Bakkeren, J. A. J. M., Schoonderwaldt, H. C., Kleijer, W. J., & Kloppenborg, P. W. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509193131201 · Cited by 732
Kang, S. S., WONG, P. W. K., Susmano, A., Sora, J., Norušis, M. J., & Ruggie, N. (1991) · PubMed · Cited by 600
Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.
Malinow, M. R., Kang, S. S., Taylor, L. M., Wong, P. W., Coull, B., Inahara, T., Mukerjee, D., Sexton, G., & Upson, B. (1989) · Circulation · doi:10.1161/01.cir.79.6.1180 · Cited by 501
Self-citationMa, J., Stampfer, M. J., Hennekens, C. H., Frosst, P., Selhub, J., Horsford, J., Malinow, M. R., Willett, W. C., & Rozen, R. (1996) · Circulation · doi:10.1161/01.cir.94.10.2410 · Cited by 479
Self-citationLentz, S. R., & Sadler, J. E. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115514 · Cited by 448
Koeleman, B., Reitsma, P., Allaart, C., & Bertina, R. (1994) · Blood · doi:10.1182/blood.v84.4.1031.1031 · Cited by 445
Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V
Voorberg, J., Roelse, J., Mertens, K., van Mourik, J. A., Koopman, R., Büller, H., Berends, F., & ten Cate, J. W. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92939-4 · Cited by 426
Zöller, B., & Dahlbäck, B. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92940-8 · Cited by 404
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.
Rodgers, G. M., & Kane, W. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112519 · Cited by 384
A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.
Verhoef, P., Hennekens, C. H., Malinow, M. R., Kok, F. J., Willett, W. C., & Stampfer, M. J. (1994) · Stroke · doi:10.1161/01.str.25.10.1924 · Cited by 379
Self-citationIs hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
den Heijer, M., Gerrits, W. B. J., Haak, H. L., Wijermans, P. W., Bos, G. M. J., Blom, H. J., & Rosendaal, F. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90008-x · Cited by 367
Coexistence of Hereditary Homocystinuria and Factor V Leiden — Effect on Thrombosis
Mandel, H., Brenner, B., Berant, M., Rosenberg, N., Lanir, N., Jakobs, C., Fowler, B., & Seligsohn, U. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341204 · Cited by 257
High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.
Falcon, C. R., Cattaneo, M., Panzeri, D., Martinelli, I., & Mannucci, P. M. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1080 · Cited by 247
Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism
Ridker, P. M., Miletich, J. P., Stampfer, M. J., Goldhaber, S. Z., Lindpaintner, K., & Hennekens, C. H. (1995) · Circulation · doi:10.1161/01.cir.92.10.2800 · Cited by 243
Self-citationFactor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency
van Boven, H. H., Reitsma, P. H., Rosendaal, F. R., Bayston, T. A., Chowdhury, V, Borg, J.-Y., Bauer, K. A., Scharrer, I., Conard, J., & Lane, D. A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650289 · Cited by 230
Fermo, I., D'Angelo, S. V., Paroni, R., Mazzola, G., Calori, G., & D'Angelo, A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-10-199511150-00002 · Cited by 225
Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease.
Kang, S. S., Passen, E. L., Ruggie, N., Wong, P. W., & Sora, H. (1993) · Circulation · doi:10.1161/01.cir.88.4.1463 · Cited by 224
Can Lowering Homocysteine Levels Reduce Cardiovascular Risk?
Stampfer, M. J., & Malinow, M. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320511 · Cited by 198
Self-citationThermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease
Kang, S.-S., Wong, P. W. K., Zhou, J., Sora, J., Lessick, M., Ruggie, N., & Grcevich, G. (1988) · Metabolism · doi:10.1016/0026-0495(88)90076-5 · Cited by 171
Cattaneo, M., Tsai, M. Y., Bucciarelli, P., Taioli, E., Zighetti, M. L., Bignell, M., & Mannucci, P. M. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.9.1662 · Cited by 164
Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease.
SKang, S., LPassen, E., NRuggie, WWong, P., & HSora (1993) · Circulation · Cited by 139
Homocyst(e)inemia in daily practice
MALINOW, M. R., Sexton, G. J., Averbuch, M., et al. (1990) · Coronary Artery Disease · doi:10.1097/00019501-199003000-00010 · Cited by 132
Self-citationGandrille, S., Greengard, J. S., Alhenc‐Gelas, M., Juhan-Vague, I., Abgrall, J., Jude, B., Griffin, J. H., & Aiach, M. (1995) · Blood · doi:10.1182/blood.v86.1.219.bloodjournal861219 · Cited by 113
Plasma Homocysteine in Venous Thromboembolism
Brattström, L. E., Tengborn, L., Lagerstedt, C., Israelsson, B., & Hultberg, B. L. (2009) · Haemostasis · doi:10.1159/000216202 · Cited by 96
Smolin, L. A., & Schneider, J. A. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90332-6 · Cited by 90
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
Cattaneo, M., Martinelli, I., & Mannucci, P. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609263351313 · Cited by 74
Plasma Homocysteine Levels in Patients With Deep Venous Thrombosis
Amundsen, T., Ueland, P. M., & Waage, A. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1321 · Cited by 71
Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease
Thiele, B. L. (1987) · Journal of Vascular Surgery · doi:10.1016/0741-5214(87)90078-4 · Cited by 56
Cited by
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Self-citationHomocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09032-6 · Cited by 1,229
Homocysteine and vascular disease
Hankey, G. J., & Eikelboom, J. W. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11058-9 · Cited by 1,052
Metadata
- Authors
- Ridker, P. M., Hennekens, C. H., Selhub, J., Miletich, J. P., Malinow, M. R., & Stampfer, M. J.
- Venue
- Circulation
- Published
- 1997-04
- Volume
- 95
- Issue
- 7
- Pages
- 1777-1782
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1994044028
- Cited by
- 338
- References
- 42
- FWCI
- 22.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.